INTRODUCTION
Human protein 4.1R, an 80 kDa polypeptide, is a key structural component of the erythrocyte membrane skeleton and plays an essential role in maintaining cell shape and bestowing membrane mechanical stability. In mature erythrocytes, 4.1R interacts with spectrin and actin to form a junctional complex in the skeletal network and it also links the network to the membrane through interactions with GPC (glycophorin C) and band 3 [1, 2] . It has been documented that a large number of 4.1R isoforms are generated through alternative splicing in a variety of cells and tissues ranging in size from 135 kDa to 60 kDa [3] [4] [5] . The multiple isoforms exhibit development-specific expression patterns in a variety of non-erythroid cells as well as in erythroblasts at different stages of development [5, 6] . There is also marked heterogeneity in the sub-cellular localization of various 4.1R isoforms in cells. During erythropoiesis two major isoforms of protein 4.1R, a 135 kDa isoform (4.1R 135 ) and an 80 kDa isoform (4.1R 80 ) , are expressed at distinct stages of terminal erythroid differentiation [3, 4] . The 4.1R 135 isoform is exclusively expressed in early erythroblasts and is not present in mature erythrocytes, whereas the 4.1R 80 isoform is expressed at late stages of erythroid differentiation and is the principal component of mature erythrocytes. The erythroid 4.1R 135 isoform includes an additional 209 amino acids designated as the HP (head-piece) at the N-terminus of 4.1R 80 , and it also lacks a stretch of 21 amino acids that are critical for the interaction of 4.1R with spectrin [6] . An extensive series of biochemical and biophysical studies have provided detailed insights into the nature of the interaction of erythroid 4.1R 80 with its various binding partners and the functional sequeli of these interactions in mature erythrocytes [7] . In contrast, little or no such information is presently available on the 4.1R 135 isoform expressed in erythroblasts. Limited chymotryptic digestion of erythroid 4.1R 80 generates four structural domains: the N-terminal 30 kDa membranebinding domain {also termed the FERM (4.1/ezrin/radixin/ moesin) domain [8] }, the 16 kDa regulatory domain, the 10 kDa SAB (spectrin-and actin-binding domain) and the 22/ 24 kDa CTD (C-terminal domain). In mature erythrocytes, the 30 kDa membrane-binding domain mediates the binding of 4.1R 80 to the plasma membrane via GPC, band 3 and p55, a type II PDZ protein. The crystal structure of the 30 kDa domain of 4.1R has been determined and is found to be composed of N-, α-and Clobes arranged in a clover-like shape [9] . The binding sites of band 3, GPC and p55 have been mapped to the N-, α-and Clobes respectively, and the binding domain for CaM has been localized to the central region of the structure [7] . The binding sites for spectrin and actin in the 10 kDa SAB domain have also been delineated [10] . Phosphorylation of Ser 312 in the 16 kDa regulatory domain by protein kinase C has been shown to decrease [17] . The effects of CaM binding to the HP on the 30 kDa domain binding to membrane proteins has not been defined. Based on currently available information [7, 13, 17] 
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Materials
pET31b and pGEX-4T2 bacterial expression vectors were purchased from Novagen and GE Healthcare Sciences respectively. Glutathione-Sepharose CL-6B and CaM-Sepharose were from GE Healthcare Sciences. All other reagents were purchased from Wako Pure Chemical Industries unless otherwise noted. IAsys ® cuvettes coated with aminosilane were obtained from Affinity Sensors.
Antibodies
A mouse monoclonal antibody against GPC (#M820) was from Dako and a mouse monoclonal antibody against band 3 (extracellular region) was from Sigma-Aldrich. Alexa Fluor ® 546-conjugated goat IgG to mouse immunoglobulins was from Invitrogen. FITC-conjugated rabbit IgG to goat immunoglobulins was from Dako. A rabbit polyclonal antibody to the HP region of 4.1R for specific detection of the 4.1R 135 isoform and a rabbit polyclonal antibody to p55 were prepared in our laboratory. Antibody specificity was assessed using an immunoblot assay using purified proteins.
Preparation of recombinant proteins
Recombinant proteins of full-length 4.1R 135 and 4.1R 80 were expressed as non-tagged proteins employing a modified pET31b vector. cDNA for the various proteins corresponding to different functional domains were cloned into a pGEX-4T2 vector and DNA sequencing was carried out to validate the fidelity of the cloned sequence. Recombinant protein expression was induced by the addition of 1 mM IPTG (isopropyl β-D-thiogalactoside) to the bacterial culture. The recombinant proteins were purified as follows: first, proteins were fractionated using 35 % saturated ammonium sulfate, the protein bound to Q-Sepharose was equilibrated with 50 mM Tris/HCl (pH 7.5), containing 0.1 M NaCl, 1 mM EDTA and 1 mM 2-mercaptoethanol, and finally the bound protein was eluted with a gradient of NaCl (0.6 M). The eluted protein was applied to CaM-Sepharose equilibrated with 50 mM Tris/HCl (pH 7.5), containing 0.1 M NaCl and 0.5 mM CaCl 2 . The bound protein was eluted with 5 mM EGTA [15] . The recombinant proteins corresponding to various domains of 4.1R were expressed as GST (glutathione transferase)-fusion proteins. These included RHP (HP of 4.1R 135 ), R30 (recombinant protein of the 30 kDa domain of 4.1R; Met 210 to Phe 507 ), the 16 kDa domain, the 10 kDa SAB domain, the 22 kDa CTD and RHP-R30 (a hybrid of RHP and R30) (Figure 1 ). At the final step, the target proteins were further purified by Q-Sepharose column chromatography to remove any bacterial contamination. Preparations of recombinant band 3 cyt (the N-terminal cytoplasmic domain of band 3), GPCcyt (the cytoplasmic domain of GPC) and p55 have 4.1R 135 isoform binding to membrane proteins 143 been described previously [13, 14] . Except for the 16 kDa domain-GST fusion protein which contains a thrombin-sensitive site, GST was cleaved from all other recombinant proteins by thrombin. The purity of the expressed proteins was assessed using SDS/PAGE analysis. The protein concentration was determined as previously reported [12] .
Preparation of IOVs (inside-out vesicles) and a binding assay
IOVs depleted of peripheral protein (native IOV) and trypsinized IOVs were prepared as described by Danilov et al. [18] with minor modifications. SDS/PAGE of trypsinized IOVs indicated that band 3cyt was completely digested in this IOV preparation; however, in these IOVs GPCcyt remained intact [19] . The pelleting assay was performed as described previously [15] . Briefly, various concentrations of 4.1R proteins were incubated for 20 min at room temperature (25 • C) with IOVs in TBS [50 mM Tris/HCl (pH 7.5) containing 0.15 M NaCl]. The 4.1R proteins and IOV mixture were laid on to 150 μl of a 3.3% sucrose cushion equilibrated in TBS containing 1 mM EDTA and 1 mM dithiothreitol. The sample was centrifuged at 60 000 rev./min for 10 min at 4
• C in a TL-100 ultracentrifuge using a TLA-100 rotor (Beckman Coulter). The supernatant and precipitate were collected, treated with sample buffer and subjected to SDS/PAGE. Proteins bound to IOVs were visualized on CBB (Coomassie Brilliant Blue G250, Gelcode Blue ® ; Pierce)-stained gels and analysed with a Digital Science EDAS290 System ® (Kodak). An apparent dissociation constant at equilibrium estimated from the pelleting assay is represented as K .
Preparation of CaM
CaM purification was performed as descibed previously [13] .
Computer analysis
The theoretical molecular mass and isoelectric point (pI) of the proteins was computed based on the amino acid sequences, using the software package DNASIS ® (Hitachi).
Binding assay by RMD (resonant mirror detection)
Protein-protein and protein-peptide interactions were examined by RMD of the IAsys ® system (Affinity Sensors) [20, 21] . Immobilized protein or peptide on the cuvette is referred to in the present study as the 'ligand' and protein in solution added to the cuvette is referred to as the 'analyte'. The immobilization of proteins on the aminosilane cuvette has been described previously [12] . The binding assay was conducted in all cases in PBS at 25
• C with constant stirring. To quantify the effects of Ca 2+ and CaM on the binding of 4.1R 135 to different ligands, GPCcyt, band 3cyt and p55 were immobilized on the cuvette surface.
4.1R
135 (1 nM-approx. 2 μM) was pre-incubated with 5 μM CaM in buffer [50 mM Tris/HCl (pH 7.5), 0.1 M NaCl with 0.1 mM EGTA or 1.1 mM CaCl 2 and 1.0 mM EGTA] at 25
• C for 30 min. The binding assays used the same buffers [12, 15] .
Kinetic analysis and analysis of the ratio of analyte binding to ligand were carried out as previously described [12, 15] . + cells were purified from healthy volunteers, who had signed informed consent forms approved by the Akita University School of Medicine Committee for the Protection of Human Subjects, as previously described [23] . The purified cells were stored in liquid nitrogen until use. The thawed CD34
+ cells were suspended in IMDM (Iscove's modified Dulbecco's medium; Invitrogen) containing 30 % (v/v) FCS (fetal calf serum) and 100 units/ml DNase, and then were washed twice with IMDM containing 20 % (v/v) FCS. The cells were seeded in 50 ml polystyrene flasks (Corning Costar) at (3-5) × 10 4 cells/ml in IMDM containing 10 % (v/v) heat-inactivated pooled human AB serum, 1 % BSA, 10 mg/ml insulin, 0.5 mg/ml vitamin B 12 , 15 mg/ml folic acid, 50 nM 2-mercaptoethanol, 50 units/ml penicillin and 50 units/ml streptomycin in the presence of 10 ng/ml interleukin-3, 10 ng/ml SCF (stem cell factor) and 2 units/ml EPO (erythropoietin) at 37
• C in a 5% CO 2 incubator, as described previously [23] . After 7 days of culture, the generated cells were collected and washed twice with IMDM containing 0.3 % BSA to obtain early erythroid progenitor cells.
Immunofluorescence study
Cell samples were rinsed twice in PBS, fixed for 10 min at room temperature in PBS containing 3.5 % formaldehyde, permeabilized further with 0.2 % Triton X-100 for 5 min at room temperature and finally rinsed twice in PBS. After incubation in PBS with 10 % (v/v) goat serum and 10 mg/ml BSA to block non-specific protein binding, the fixed cells were incubated with antibodies for 1 h at room temperature in PBS containing 10 mg/ml of BSA, washed and then incubated with FITCand rhodamine-conjugated secondary antibodies. The cells were washed again and the coverslips were mounted on slides using Vectashield containing DAPI ® (4 ,6-diamidino-2-phenylindole) for nuclear staining. Controls with equivalent amounts of nonimmune IgG or primary antibody omitted were also included in each experiment. Immunofluorescent cells were imaged with a confocal microscope (LSM510-Ver3.2, Carl Zeiss) having a 63 × , 1.4 NA oil-immersion objective lens.
RESULTS
4.1R 135 binding to IOVs
SDS/PAGE analysis of non-tagged full-length recombinant 4.1R 135 used for the binding assay showed a major band at 135 kDa corresponding to full-length protein and a minor band at ∼ 100 kDa, presumably a proteolytic-cleavage product (Figure 2A, lane 1) . The membrane protein composition of native IOVs (Figure 2A, lane 2) and of trypsinized IOVs (Figure 2A, lane  4) are also shown. Note that trypsin treatment of IOVs resulted in the generation of band 3 fragments of 60 kDa that lack the cytoplasmic domain containing the 4.1R-binding site. Previous studies have shown that although 4.1R binds to both band 3 and GPC in native IOVs, it binds only to GPC in trypsinized IOVs [19] . The pelleting assay showed binding of 4.1R 135 to native IOVs (Figure 2A, lane 3) , as well as trypsinized IOVs (Figure 2A,  lane 5) .
Binding of 4.1R 135 to both band 3 and GPC on native IOVs increased with an increasing concentration of 4.1R 135 , reaching a maximum at 600 nM ( Figure 2B ). Scatchard analysis indicated an apparent dissociation constant at equilibrium, K , of 76 nM ( Figure 2C We also studied the binding of the recombinant RHP-R30 to IOVs and found that its binding affinity to both native and trypsinized IOVs was the same as those of full-length 4.1R
(results not shown). This finding suggests that all of the binding characteristics of 4.1R
135 to band 3 and GPC are accounted for by the HP and the 30 kDa domain of native protein.
Kinetic analysis of 4.1R 135 binding to membrane proteins using the RMD method
In order to obtain independent confirmation of the binding affinities of 4.1R 135 to band 3cyt and GPCcyt we used the IAsys ® system based on the RMD method (Table 1 ). In agreement with our binding data using IOVs, there was a profound difference in the binding of 4.1R 135 to band 3cyt and GPCcyt with much stronger binding to band 3cyt. The K D values for binding to these two proteins differed by almost two orders of magnitude (15 + − 1 nM for band 3 compared with 1317 + − 104 nM for GPC). In marked contrast, the K D values for binding of 4.1R 80 to both band 3cyt and GPCcyt were very similar, in the sub-micromolar range ( Table 1 ), suggesting that an important role for the HP is in regulating binding affinities. In contrast with the marked differences in the binding affinities of 4.1R 135 and 4.1R 80 to band 3cyt and GPCcyt, the two isoforms bound to p55 with very similar affinities in the sub-micromolar range (Table 1) .
To clarify the effects of RHP on the R30 interaction with its binding partners, we measured its ability to bind band 3cyt and GPCcyt with and without RHP ( Table 2) . RHP by itself did not bind to either band 3cyt or GPCcyt. As we previously reported, R30 by itself interacted with similar sub-micromolar affinities to both band 3cyt and GPCcyt (Table 2) [13, 14] . Importantly, the addition of RHP to R30 (RHP-R30), resulted in a profound differential change in its ability to bind band 3cyt and GPCcyt. The binding affinity of RHP-R30 to band 3cyt was 35-fold stronger than for GPCcyt, a finding that is very similar to that noted above for the native full-length protein in the IOV-binding assays. These findings have identified an important role for RHP in modulating the interaction of R30 with its two membrane-binding partners.
4.1R 135 binding to CaM
We previously documented that 4.1R 80 binds to CaM with a K D in the range of 100 nM both in the presence and absence of Ca 2+ , suggesting Ca 2+ -independent binding (Table 3 ) [13] . In the present study, we examined the nature of the interaction between 4.1R 135 and CaM. Kinetic analysis of the 4.1R 135 interaction with CaM using the RMD method identified a very strong interaction with a K D of 51 + − 5 nM in the presence of Ca 2+ . In the absence of Ca 2+ the affinity of the interaction decreased by over 100-fold. Thus, in contrast with 4.1R 80 , the interaction of 4.1R 135 with CaM was strongly Ca 2+ -dependent. As with binding to membrane proteins, this differential change in binding of 4.1R 135 to CaM was recapitulated by RHP-R30 (Table 3) . Furthermore, the HP region by itself exhibited Ca 2+ -dependent binding with CaM, suggesting that this region harbours the CaM-binding site (Table 3) .
To determine the stoichiometry of 4.1R 135 binding to CaM in the presence of Ca 2+ , we assessed the change in molecular mass following the interaction of the two proteins using the QCM method. To 1.57 × 10 
Regulation of interactions of 4.1R
135 with membrane-protein interactions by Ca 2+ /CaM
In a series of studies, we examined the effect of Ca 2+ /CaM on the binding of 4.1R 135 to its various binding partners ( 135 to bind either GPCcyt or p55. Either 5 μM CaM or 100 μM Ca 2+ alone had no effect on binding affinities (results not shown).
Next we examined the Ca 2+ -dependence of CaM-regulation of the binding of 4.1R 135 to band 3cyt (Figure 4 ). 4.1R 135 binding to band 3cyt started to decline beginning at Ca 2+ concentrations greater than 10 nM (pCa < 8), with maximal inhibition at a Ca 2+ concentration of 100 μM (pCa > 4). Half-maximal binding was seen at a Ca 2+ concentration of 3.2 μM (pCa = 5.5).
Localization of peripheral membrane proteins in the erythroblast
As 4.1R 135 has previously been shown to be expressed in early erythroid progenitors including pro-erythroblasts [6] , we examined the cellular localization of 4.1R 135 and its binding partners in cells at day 7 of CD34 + cultures where the predominant population of cells is pro-erythroblasts. As shown in Figure 5 , band 3 and GPC are localized to the plasma membrane, and p55 is broadly distributed in these early erythroblasts. When we looked for localization of 4.1R 135 in these cells, we noted that the protein was present both at the membrane and in the cytoplasm.
DISCUSSION
In the present study, we have described the significant differences in the nature of the interaction of the two 4.1R isoforms, 4 [14, 25] . In this stretch of 73 amino acids, 25 amino acids in the N-terminal region are predominantly hydrophobic, whereas 48 amino acids at the C-terminus are hydrophilic. It has been suggested that the E 153 LEE sequence in the hydrophilic region is likely to mediate its interaction with the R 86 HK sequence in GPC [25] , although the precise GPC-binding site on 4.1R 80 remains to be identified. The significantly weaker interaction of 4.1R 135 with GPC implies that the HP region, in contrast with its positive effect on the band 3-binding site, must somehow mask the GPC-binding site and have a negative effect on binding.
Another was strongly Ca 2+ -dependent. This difference was once again directly attributed to the HP region of 4.1R 135 . Importantly, in contrast with band 3 and GPC that do not directly bind to the HP region, this region by itself binds to CaM in a Ca 2+ -dependent manner. Leclerc and Vetter [17] have previously identified the Ca 2+ /CaM-binding site in the HP region of Xenopus. sp. 4.1 [16, 17] . This CaM-binding sequence is highly conserved between human and Xenopus 4.1. Thus it must be inferred that the CaMbinding site in the HP is the dominant binding site for CaM in 4.1R 135 , and that this site prevents the binding of CaM to the Ca 2+ -independent binding site in 4.1R 80 . Furthermore, our finding that CaM, in a Ca 2+ -dependent manner, dramatically decreases the binding of 4.1R 135 to band 3 and abolishes its binding to GPC and p55 has implications for the function of this protein in early erythroblasts. Although low levels of Ca 2+ in early erythroblasts will lead to membrane association through a highaffinity interaction with band 3, increasing levels of Ca 2+ during Figure 5 Immunochemical localization of membrane proteins in erythroblasts at day 7
In each column, images from the immunostaining (top panels) and by phase-contrast microscopy (bottom panels) are shown. In the top panels, green and red staining indicates that the primary antibodies used were either rabbit or mouse respectively. The same antibodies were used for immunoblot analysis and immunocytochemistry. Magnification in all cases is × 1000.
erythroid differentiation will lead to displacement of the protein from the membrane and possible degradation and loss of this isoform from erythroblasts [26, 27] . Our findings that a fraction of 4.1R 135 in early erythroblasts is associated with the membrane lends support to this hypothesis; however, it should be noted that quantitative measurement of Ca 2+ levels in erythroblasts at different stages of maturation needs to be established to validate this hypothesis.
